# Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis

> **NCT02721940** · NA · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 100 (actual)

## Conditions studied

- Osteonecrosis

## Interventions

- **PROCEDURE:** Control group
- **BIOLOGICAL:** Mononuclear Cells
- **BIOLOGICAL:** Platelets
- **DRUG:** Zoledronic Acid
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02721940
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2015-01
- **Final completion:** 2016-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02721940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02721940, "Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02721940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*